ofloxacin has been researched along with Bacterial Eye Infections in 118 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 22 (18.64) | 18.2507 |
2000's | 70 (59.32) | 29.6817 |
2010's | 23 (19.49) | 24.3611 |
2020's | 3 (2.54) | 2.80 |
Authors | Studies |
---|---|
Das, S; Gunasekaran, R; Mitra, S; Mohamed, A; Prajna, L; Prajna, NV; Sharma, S; Soni, T | 1 |
Essex, RW; Maddess, T; Pearce, JG | 1 |
Behera, HS; Dutta, A; Priyadarshini, SR; Sahu, S | 1 |
Abdelkhalek, A; Bergstrom, BE; Hammac, GK; Seleem, MN; Townsend, WM; Younis, W | 1 |
Ayres, M; Chan, E | 1 |
Petsoglou, C; Samarawickrama, C; Tran, T; Watson, S | 1 |
Bozbıyık, Dİ; Eğrilmez, S; Ertan, G; Gökçe, EH; Özer, Ö; Üstündağ-Okur, N | 1 |
Fernandes, M; Kumar, N; Medikonda, R; Vira, D | 1 |
Khan, A; Koenekoop, RK; Mikhail, M | 1 |
Rocke, J; Roydhouse, T; Spencer, T | 1 |
Georgakopoulos, CD; Georgalas, I; Makri, OE; Pharmakakis, N; Plotas, P; Vantarakis, A | 1 |
Eisen, L; Kim, J; Rosenberg, J | 1 |
Anderson, D; Hossain, P; Konstantopoulos, A; Kuo, J | 1 |
Fiscella, RG; Jensen, MK; Mooney, B; Moshirfar, M | 1 |
Kobayakawa, S; Tochikubo, T; Tsuchiya, Y; Tsuji, A | 1 |
Holland, EJ; Lane, SS; Lindstrom, RL | 1 |
McCulley, JP | 1 |
Alam, MR; Garg, P; Gopinathan, U; Krishnaiah, S; Reddy, AK; Sharma, S | 1 |
Ahogo, C; Cisse, M; Ecra, E; Gbery, I; Kacou, E; Kanga, JM; Kassi, K; Kouame, K; Kouassi, A; Yoboue, P | 1 |
Cheng, L; Congdon, N; Lam, PT; Tam, PM; Young, AL | 1 |
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
Anderson, DF; Fievez, M; Hossain, P; Konstantopoulos, A; Yadegarfar, G | 1 |
Fukumoto, A; Hieda, O; Kinoshita, S; Sotozono, C | 1 |
Goto, T; Kodama, T; Ohashi, Y; Zheng, X | 1 |
Alekperov, SI; Boĭko, ÉV; Fokina, DV; Reĭtuzov, VA | 1 |
Garg, S; Milder, E; Shah, C; Vander, J | 1 |
Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA | 1 |
Cernak, A; Cernak, M; Majtan, J; Majtanova, N | 1 |
Hafezi, F | 1 |
Chen, ZJ; Han, L; Sun, ST; Wang, LY; Yue, J; Zhang, YQ | 1 |
Fukumoto, M; Hashimoto, M; Ishida, C; Kanda, Y; Kayama, T; Kunihiro, E; Okamoto, S; Yanai, T | 1 |
Kawasaki, S; Mito, T; Ohashi, Y; Suzuki, T; Tasaka, Y; Uda, T; Uno, T | 1 |
Feng, L; Gao, Q; Huang, X; Jiang, Z; Li, Y; Lin, J; Lin, X; Liu, Y; Wang, T; Xie, Z | 1 |
Gehrs, KM; Heilskov, TW; Kherani, A; Kherani, F; Sutphin, JE; Wagoner, MD | 1 |
Blumenkranz, MS; Egbert, PR; Miño De Kaspar, H; Shriver, EM; Singh, K; Ta, CN | 1 |
Fujita, A; Inagaki, K; Inatomi, T; Kinoshita, S; Koizumi, N; Sano, Y; Sotozono, C | 1 |
Chen, F; Hu, Y; Zhang, M | 1 |
Carpenter, TR; Kaufman, MB; McDonnell, PJ; Sarayba, MA; Sweet, PM; Taban, M; Tungsiripat, T | 1 |
Biser, S; Donnenfeld, ED; Perry, HD; Solomon, R | 1 |
Bloom, AH; Davis, RG; Donnenfeld, ED; Perry, HD | 1 |
Matoba, AY | 1 |
Fleiszig, SM; Lee, EJ; Mendoza, MN; Truong, TN | 1 |
Barequet, IS; Denton, P; O'Brien, TP; Osterhout, GJ; Tuli, S | 1 |
Hwang, DG | 1 |
Blumenkranz, MS; de Kaspar, HM; Egbert, PR; Singh, K; Ta, CN | 1 |
Blumenkranz, MS; Chang, RT; De Kaspar, HM; Egbert, PR; Shriver, EM; Singh, K; Ta, CN | 1 |
Caballero, AR; Dajcs, JJ; Girgis, DO; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA | 1 |
Lang, J; Rah, MJ | 1 |
Alió, JL; Ferrer, C; Montero, J; Rodríguez, A; Ruiz-Moreno, JM | 1 |
Crandall, AS; Fiscella, RG; Jensen, MK; Mooney, B; Moshirfar, M; Olson, RJ; Wallin, T | 1 |
Gurkan, T; Oguz, E; Oguz, H; Ozbilge, H | 1 |
Hasegawa, M; Kobayashi, I; Koyama, H; Matsuzaki, K; Sato, Y; Watabe, E | 1 |
Jin, X; Li, R; Liang, Q; Luo, S; Sun, X; Wang, Z | 1 |
Almer, Z; Avni, I; Barkana, Y; Lazarovitch, Z; Segal, O; Zadok, D | 1 |
Graff, JM; Kesler-Diaz, A; McDonnell, PJ; Osann, KE; Reiser, BJ; Sarayba, MA; Shamie, N; Sweet, PM; Taban, M | 1 |
Araki-Sasaki, K; Asari, S; Matsumoto, K; Mutoh, K; Nishi, I; Takatsuka, H; Tanihara, H; Yonemura, N | 1 |
Freisberg, L | 1 |
Starr, MB | 1 |
Katz, HR | 1 |
Caballero, AR; Dajcs, JJ; Johnston, KH; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA | 1 |
Al-Khattaf, AS; Al-Mansouri, SM; Begum, NN; Kambal, AM; Yeboah, EA | 1 |
Barry, P; Gettinby, G; Lees, F; Peterson, M; Revie, CW; Seal, DV; Wilhelmus, KR | 1 |
Barry, P; Gettinby, G; Lees, F; Peterson, M; Revie, CW; Seal, DV | 1 |
Maden, A; Saklamaz, A; Yilmaz, S | 1 |
Bayar, B; Bozkurt, A; Dinçel, A; Duman, S; Kaya, E; Oflu, Y; Yağci, R; Yağci, S | 1 |
Fukaya, Y; Hirata, H; Kamata, Y; Kambara, Y; Kurasawa, N; Kurita, A; Naito, A; Nakaya, S; Ohashi, Y; Sato, M; Shirasawa, E; Toyoda, Y; Tsuruga, H; Wada, T | 1 |
Bohigian, GM | 1 |
Asbell, PA; Bottone, EJ; Epstein, SP | 1 |
McDonald, MB | 1 |
Altaie, R; Cormican, M; Fahy, GT | 1 |
D'Azevedo, PA; Francisco, W; Oliveira, AD | 1 |
Oguz, H | 1 |
Donnenfeld, ED; Ehrenhaus, M; Maloney, RK; Manche, EE; Matzkin, DC; Moshirfar, M; Mozayeni, RM; Perry, HD; Rubinfeld, RS; Solomon, KD; Solomon, R; Wittpenn, JR | 1 |
Lee, PY; Liang, YB; Qiao, LY; Wan, XH; Wang, NL; Zhu, SQ | 1 |
Spokes, DM; Walters, G | 1 |
Anderson, DF; Kailasanathan, A | 1 |
Altiparmak, UE; Aslan, BS; Duman, S; Ozer, PA; Ozkuyumcu, C; Us, AD | 1 |
Constantinou, M; Daniell, M; Snibson, GR; Taylor, HR; Vu, HT | 1 |
Cantor, LB; Catoira, YP; Hoop, JS; Morgan, LS; Valluri, S; WuDunn, D; Yung, CW | 1 |
El Mallah, MK; Janda, WM; Munir, WM; Tu, EY | 1 |
Alfonso, E; Fink, NE; Maguire, MG; McDonnell, P; O'Brien, TP | 1 |
Bing Hoh, H; Diamond, JP; Easty, DL; Leeming, JP; White, L | 1 |
Hatano, H; Isobe, Y; Ohno, S; Shiao, S | 1 |
Kamata, R; Maeda, H; Matsumoto, K; Miyagawa, S; Okamura, R | 1 |
Baker, RS; Casey, R; Flowers, CW; Fong, DS; Wilson, MR | 1 |
Procope, JA | 1 |
Inoue, Y; Maeda, N; Sato, S; Shimomura, Y; Tano, Y; Watanabe, H | 1 |
Friedlaender, MH | 1 |
Engel, LS; Green, LC; Hill, JM; Moreau, JM; O'Callaghan, RJ | 1 |
Goldstein, MH; Gordon, YJ; Kowalski, RP | 1 |
Butcher, J; Minassian, D; Morlet, N | 1 |
Basci, NE; Batman, C; Bozkurt, A; Cekiç, O; Kayaalp, SO; Totan, Y; Yasar, U; Zilelioglu, O | 1 |
Basci, N; Bozkurt, A; Ilker, SS; Inan, UU; Kortunay, S; Kurt, E; Oztürk, F | 1 |
Ahuja, R; Panda, A; Sastry, SS | 1 |
Chuang, AZ; Kiang, E; Mitra, S; Patel, GM; Ramesh, N; Yee, RW | 1 |
Goldberg, MA; Lustbader, J; MacDowell, AL; Melki, SA; Safar, A; Scharper, M; Scharper, P; Yaghouti, F; Zeligs, B | 1 |
Alexandrakis, G; Alfonso, EC; Miller, D | 1 |
Chuang, AZ; Hashemi, K; Lanier, JD; Schweitzer, C | 1 |
Booth, MC; Callegan, MC; Gilmore, MS | 1 |
Fong, Y; Kampmeier, J; LaBree, LD; McDonnell, PJ; Rao, SN; Tanzer, DJ | 1 |
Daniell, M; Mallari, PL; McCarty, DJ; Taylor, H | 1 |
George, C; Lu, KL; McDonnell, PJ; Prajna, NV; Selvaraj, S; Srinivasan, M | 1 |
Eiferman, RA | 1 |
McAllister, L; Metcalf, C; Tandon, A; Tay-Kearney, ML | 1 |
Gordon, YJ; Husted, RC; Karenchak, LM; Kowalski, RP; Pandya, AN; Ritterband, DC; Romanowski, EG; Shah, MK | 1 |
Austin, MS; Dajcs, JJ; Marquart, ME; Moreau, JM; O'Callaghan, RJ; Stroman, DW; Thibodeaux, BA; Traidej, M | 1 |
Caballero, AR; Dajcs, JJ; Girgis, DO; Ke, TL; Moreau, JM; O'Callaghan, RJ; Schlech, BA; Stroman, DW; Thibodeaux, BA | 1 |
Apel, A; Hutchinson, K | 1 |
Karenchak, LM; Kowalski, RP; Mather, R; Romanowski, EG | 1 |
Gauderman, WJ; Gritz, DC; Gwon, A; Jones, R; Kwitko, S; Litwin, KL; McDonnell, PJ; Moreira, H; Ohadi, C | 1 |
Gwon, A | 1 |
Adenis, JP; Chauvin, M; Denis, F; Mounier, M; Ploy, MC | 1 |
Gritz, DC; Gwon, A; Hubbard, BB; Lee, TY; McDonnell, PJ; Tang-Liu, D | 1 |
Oomomo, A | 1 |
Baig, H; Bron, AJ; Elkington, AR; Harden, A; Kirkby, GR; Leber, G; Leong, T; Neoh, C; Rizk, SN | 1 |
4 review(s) available for ofloxacin and Bacterial Eye Infections
Article | Year |
---|---|
The clinical treatment of bacterial keratitis: A review of drop instillation regimes.
Topics: Ciprofloxacin; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratitis; Ofloxacin | 2022 |
Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Drug Resistance, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Ophthalmology; Quinolines | 2004 |
Research review and update: IQUIX (levofloxacin 1.5%).
Topics: Animals; Anti-Bacterial Agents; Bacteria; DNA, Bacterial; Eye Infections, Bacterial; Humans; Levofloxacin; Ofloxacin; Ophthalmic Solutions; Tears; Treatment Outcome | 2006 |
[Study of intraocular diffusion of ofloxacin in humans and rabbits].
Topics: Aged; Animals; Aqueous Humor; Cataract Extraction; Diffusion; Eye; Eye Infections, Bacterial; Humans; Injections, Intravenous; Ofloxacin; Preoperative Care; Rabbits; Staphylococcus epidermidis | 1992 |
22 trial(s) available for ofloxacin and Bacterial Eye Infections
Article | Year |
---|---|
Efficacy of Topical Ofloxacin 0.3 % Administration on Conjunctival Bacterial Flora in Diabetic Patients Undergoing Intravitreal Injections.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anti-Bacterial Agents; Bacteria; Conjunctiva; Diabetic Retinopathy; Drug Administration Schedule; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies | 2017 |
Honey prophylaxis reduces the risk of endophthalmitis during perioperative period of eye surgery.
Topics: Abies; Anti-Bacterial Agents; Cataract Extraction; Corynebacterium; Drug Evaluation; Endophthalmitis; Enterococcus; Eye Infections, Bacterial; Honey; Humans; Ofloxacin; Ophthalmic Solutions; Perioperative Period; Pilot Projects; Staphylococcus; Vitrectomy | 2012 |
Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Bacteria; Cataract Extraction; Colony Count, Microbial; Conjunctiva; Eye Infections, Bacterial; Humans; Ofloxacin; Prospective Studies; Time Factors | 2002 |
[Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Conjunctivitis, Bacterial; Eye Infections, Bacterial; Female; Humans; Keratitis; Levofloxacin; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions | 2000 |
The challenge of determining aqueous contamination rate in anterior segment intraocular surgery.
Topics: Anterior Eye Segment; Anti-Infective Agents; Aqueous Humor; Bacteria; Catheterization; Eye Infections, Bacterial; Humans; Ofloxacin; Ophthalmic Solutions; Phacoemulsification; Prospective Studies; Surgical Wound Infection | 2004 |
Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in cataract surgery: a prospective randomized study.
Topics: Administration, Topical; Anti-Infective Agents; Antibiotic Prophylaxis; Colony Count, Microbial; Conjunctiva; Equipment Contamination; Eye Infections, Bacterial; Humans; Ofloxacin; Ophthalmic Solutions; Phacoemulsification; Prospective Studies; Time Factors | 2004 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Double-Blind Method; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections; Levofloxacin; Ofloxacin; Postoperative Complications; Prospective Studies | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Double-Blind Method; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections; Levofloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prospective Studies | 2006 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Lens Implantation, Intraocular; Levofloxacin; Male; Odds Ratio; Ofloxacin; Phacoemulsification; Postoperative Complications; Prospective Studies; Risk Factors | 2007 |
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Child; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ofloxacin; Prospective Studies; Quinolines; Tobramycin; Treatment Outcome | 2007 |
Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial.
Topics: Administration, Oral; Anti-Bacterial Agents; Aqueous Humor; Cataract Extraction; Ciprofloxacin; Drug Therapy, Combination; Eye Infections, Bacterial; Filtering Surgery; Humans; Levofloxacin; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Single-Blind Method; Surgical Wound Infection | 2008 |
Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Cornea; Corneal Ulcer; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Tobramycin; Treatment Outcome | 1995 |
Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefuroxime; Cephalosporins; Cornea; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Follow-Up Studies; Fungi; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Treatment Outcome | 1997 |
Twice-a-day versus four-times-a-day ofloxacin treatment of external ocular infection.
Topics: Administration, Topical; Anti-Infective Agents; Bacteria; Blepharitis; Colony Count, Microbial; Conjunctiva; Conjunctivitis, Bacterial; Drug Administration Schedule; Eye Infections, Bacterial; Eyelids; Female; Follow-Up Studies; Humans; Male; Ofloxacin; Ophthalmic Solutions; Treatment Outcome | 1998 |
Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group.
Topics: Adolescent; Aged; Aged, 80 and over; Anti-Infective Agents; Cefuroxime; Cephalosporins; Eye Infections, Bacterial; Female; Gentamicins; Humans; Keratitis; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Ophthalmic Solutions; Prognosis; Prospective Studies; Risk Factors; Treatment Failure | 1999 |
Penetration of topical, oral, and combined administered ofloxacin into the subretinal fluid.
Topics: Administration, Oral; Administration, Topical; Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Body Fluids; Eye Infections, Bacterial; Female; Humans; Male; Ofloxacin; Retina; Retinal Detachment | 1999 |
Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Staphylococcal Infections; Tobramycin; Visual Acuity | 1999 |
Epithelial healing rates with topical ciprofloxacin, ofloxacin, and ofloxacin with artificial tears after photorefractive keratectomy.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Ciprofloxacin; Corneal Topography; Drug Therapy, Combination; Epithelium, Corneal; Eye Infections, Bacterial; Female; Fluorophotometry; Humans; Lasers, Excimer; Male; Middle Aged; Myopia; Ofloxacin; Ophthalmic Solutions; Photorefractive Keratectomy; Wound Healing | 2000 |
Comparison of antibiotic drops placed in the conjunctival cul-de-sac to antibiotic ointment applied to the lid margin in reduction of bacterial colonization on the lid margin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacitracin; Bacteria; Colony Count, Microbial; Conjunctiva; Drug Resistance, Microbial; Erythromycin; Eye Infections, Bacterial; Eyelid Diseases; Eyelids; Female; Gentamicins; Humans; Male; Middle Aged; Ofloxacin; Ointments; Ophthalmic Solutions; Prospective Studies; Single-Blind Method | 2000 |
Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis.
Topics: Adult; Anti-Infective Agents; Bacteria; Ciprofloxacin; Corneal Ulcer; Double-Blind Method; Drug Administration Schedule; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Safety; Time Factors; Treatment Outcome | 2001 |
Topical ofloxacin compared with gentamicin in the treatment of external ocular infection. Ofloxacin Study Group.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Blepharitis; Conjunctivitis; Eye Infections, Bacterial; Female; Gentamicins; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions | 1992 |
Ofloxacin compared with chloramphenicol in the management of external ocular infection.
Topics: Adult; Aged; Aged, 80 and over; Blepharitis; Chloramphenicol; Conjunctivitis; Double-Blind Method; Eye Infections, Bacterial; Humans; Middle Aged; Ofloxacin | 1991 |
92 other study(ies) available for ofloxacin and Bacterial Eye Infections
Article | Year |
---|---|
Corynebacterium Keratitis: Pure Versus Mixed Infection and Antibiotic Susceptibility Patterns From Different Tertiary Eye Care Centers.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Coinfection; Corynebacterium; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Retrospective Studies; Tertiary Care Centers; Vancomycin | 2022 |
Topics: Anti-Bacterial Agents; Child; Corynebacterium; Eye Infections, Bacterial; Humans; Keratitis; Male; Microbial Sensitivity Tests; Ofloxacin | 2021 |
Antibacterial activity and safety of commercial veterinary cationic steroid antibiotics and neutral superoxidized water.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Cations; Cell Line; Dog Diseases; Dogs; Drug Resistance, Microbial; Eye; Eye Infections, Bacterial; Gentamicins; Humans; Hydrogen Peroxide; Mice; Microbial Sensitivity Tests; Ofloxacin; Ophthalmic Solutions; Steroids; Tobramycin; Veterinary Drugs | 2018 |
Corneal Perforation With Iris Plugging.
Topics: Anti-Bacterial Agents; Corneal Perforation; Cyanoacrylates; Eye Infections, Bacterial; Humans; Iris Diseases; Male; Middle Aged; Ofloxacin; Streptococcal Infections; Streptococcus constellatus; Tissue Adhesives; Tomography, Optical Coherence; Vision Disorders; Visual Acuity | 2018 |
Recent cluster of childhood microbial keratitis due to orthokeratology.
Topics: Acanthamoeba Keratitis; Adolescent; Anti-Bacterial Agents; Biguanides; Cephalothin; Child; Chlorhexidine; Cluster Analysis; Corneal Ulcer; Disinfectants; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Male; Ofloxacin; Orthokeratologic Procedures; Pseudomonas Infections | 2014 |
Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis.
Topics: Animals; Biological Availability; Cornea; Drug Delivery Systems; Excipients; Eye Infections, Bacterial; Keratitis; Lipids; Nanostructures; Ofloxacin; Polyethylene Glycols; Rabbits; Staphylococcus aureus; Treatment Outcome | 2015 |
Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Female; Humans; Imipenem; Keratoplasty, Penetrating; Male; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Visual Acuity | 2016 |
Orbital cellulitis and multiple abscess formation after strabismus surgery.
Topics: Abscess; Administration, Topical; Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Drug Therapy, Combination; Erythromycin; Exotropia; Eye Infections, Bacterial; Female; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Oculomotor Muscles; Ofloxacin; Ophthalmologic Surgical Procedures; Orbital Cellulitis; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Canaliculitis caused by Citrobacter freundii.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Canaliculitis; Cefazolin; Citrobacter freundii; Combined Modality Therapy; Curettage; Drug Therapy, Combination; Enterobacteriaceae Infections; Eye Infections, Bacterial; Female; Humans; Ofloxacin | 2016 |
Moxifloxacin for bacterial keratitis.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Ofloxacin; Quinolines; Randomized Controlled Trials as Topic; Tobramycin; Treatment Outcome | 2008 |
Assessment of the use of anterior segment optical coherence tomography in microbial keratitis.
Topics: Adult; Aged; Anterior Eye Segment; Anti-Bacterial Agents; Cefuroxime; Contact Lenses; Corneal Ulcer; Corynebacterium; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Longitudinal Studies; Male; Middle Aged; Ofloxacin; Prospective Studies; Pseudomonas aeruginosa; Risk Factors; Staphylococcus aureus; Tomography, Optical Coherence | 2008 |
Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Cross-Sectional Studies; Endophthalmitis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Middle Aged; Moxifloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Quinolines; Retrospective Studies | 2008 |
Preventive effect against post-cataract endophthalmitis: drug delivery intraocular lens versus intracameral antibiotics.
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Aqueous Humor; Biological Availability; Cataract Extraction; Chromatography, High Pressure Liquid; Colony Count, Microbial; Drug Delivery Systems; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacterial Infections; Lens Implantation, Intraocular; Lenses, Intraocular; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Postoperative Complications; Rabbits | 2008 |
Fluoroquinolones and postoperative endophthalmitis.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Quinolines | 2009 |
Fluoroquinolones and postoperative endophthalmitis.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Moxifloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Quinolines | 2009 |
Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacterial Infections; Humans; India; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Retrospective Studies; Staphylococcus; Streptococcus | 2010 |
[Buruli ulcer involving the head: outcomes and therapeutic aspects in 8 cases observed at the University Hospital Center in Abidjan, Cote d'Ivoire].
Topics: Adolescent; Anti-Bacterial Agents; Anticoagulants; Buruli Ulcer; Child; Child, Preschool; Cote d'Ivoire; Enoxaparin; Eye Infections, Bacterial; Face; Female; Humans; Male; Ofloxacin; Rifampin; Severity of Illness Index; Soft Tissue Infections; Young Adult | 2008 |
Tsukamurella: an unrecognized mimic of atypical mycobacterial keratitis? The first case report.
Topics: Actinomycetales; Actinomycetales Infections; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Corneal Ulcer; Diagnosis, Differential; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Keratoplasty, Penetrating; Male; Mycobacterium Infections; Ofloxacin; Reoperation | 2010 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
In vivo quantification of bacterial keratitis with optical coherence tomography.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; Cornea; Corneal Ulcer; Drug Monitoring; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Pseudomonas Infections; Tomography, Optical Coherence; Young Adult | 2011 |
Infectious keratitis caused by fluoroquinolone-resistant Corynebacterium.
Topics: Corneal Ulcer; Corynebacterium; Corynebacterium Infections; Drug Resistance, Bacterial; Eye Infections, Bacterial; Female; Fluorometholone; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Photorefractive Keratectomy | 2011 |
Autologous fascia lata grafts for scleral repair in eyes with infectious necrotizing scleritis.
Topics: Aged; Amnion; Ceftazidime; Eye Infections, Bacterial; Eye Infections, Fungal; Fascia Lata; Female; Humans; Male; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Sclera; Scleritis; Transplantation, Autologous | 2011 |
[The effectiveness of intraocular delivery of 5-fluoroquinolones for prophylaxis of intraocular infection].
Topics: Anti-Bacterial Agents; Aza Compounds; Eye Infections, Bacterial; Eye Injuries; Female; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intraocular; Levofloxacin; Male; Military Medicine; Moxifloxacin; Ofloxacin; Quinolines; Warfare | 2011 |
Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteria; Case-Control Studies; Conjunctiva; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Intravitreal Injections; Macular Degeneration; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Polymyxin B; Quinolines; Trimethoprim | 2012 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Eye Infections, Fungal; Eye Infections, Parasitic; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies | 2012 |
Significant visual increase following infectious keratitis after collagen cross-linking.
Topics: Anti-Bacterial Agents; Collagen; Corneal Stroma; Corneal Topography; Corneal Ulcer; Cross-Linking Reagents; Eye Infections, Bacterial; Humans; Keratoconus; Male; Microscopy, Confocal; Ofloxacin; Photosensitizing Agents; Postoperative Complications; Riboflavin; Staphylococcal Infections; Ultraviolet Rays; Vision Disorders; Visual Acuity; Young Adult | 2012 |
[The changes of ocular bacterial isolates and in vitro antimicrobial susceptibility in the past six years].
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Eye; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus epidermidis; Tobramycin | 2012 |
Post-marketing surveillance of levofloxacin 0.5% ophthalmic solution for external ocular infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Eye Infections; Eye Infections, Bacterial; Female; Humans; Infant; Infant, Newborn; Japan; Levofloxacin; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Product Surveillance, Postmarketing; Treatment Outcome; Young Adult | 2012 |
Moxifloxacin as postoperative prophylaxis for Enterococcus faecalis-induced endophthalmitis after cataract surgery in aphakic rabbits.
Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Aphakia, Postcataract; Aza Compounds; Disease Models, Animal; Electroretinography; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Fluoroquinolones; Gram-Positive Bacterial Infections; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Phacoemulsification; Quinolines; Rabbits; Time Factors | 2013 |
A preliminary study to treat severe endophthalmitis via a foldable capsular vitreous body with sustained levofloxacin release in rabbits.
Topics: Animals; Anti-Bacterial Agents; Ciliary Body; Colony Count, Microbial; Cytokines; Drug Delivery Systems; Drug Implants; Endophthalmitis; Eye Infections, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rabbits; Real-Time Polymerase Chain Reaction; RNA, Messenger; Staphylococcal Infections; Staphylococcus epidermidis; Vitreous Body | 2013 |
Xanthomonas maltophilia endophthalmitis following penetrating corneal injury.
Topics: Amphotericin B; Cornea; Corneal Injuries; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Fluconazole; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Ofloxacin; Stenotrophomonas maltophilia; Visual Acuity | 2002 |
Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Child; Dibekacin; Eye Infections, Bacterial; Female; Humans; Incidence; Keratitis; Male; Methicillin; Methicillin Resistance; Middle Aged; Ofloxacin; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2002 |
Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Keratitis; Keratomileusis, Laser In Situ; Levofloxacin; Ofloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Surgical Flaps | 2003 |
Bilateral methicillin-resistant staphylococcus aureus keratitis in a medical resident following an uneventful bilateral photorefractive keratectomy.
Topics: Adult; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Eyelids; Female; Humans; Internship and Residency; Lasers, Excimer; Methicillin Resistance; Ofloxacin; Photorefractive Keratectomy; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Chryseobacterium meningosepticum keratitis.
Topics: Bacitracin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Ofloxacin; Retrospective Studies | 2003 |
Polymicrobial keratitis secondary to Burkholderia ambifaria, enterococcus, and staphylococcus aureus in a patient with herpetic stromal keratitis.
Topics: Amikacin; Burkholderia; Burkholderia Infections; Corneal Stroma; Drug Therapy, Combination; Enterococcus; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratitis, Herpetic; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cornea; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Glucocorticoids; Mice; Mice, Inbred C57BL; Ofloxacin; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2003 |
Treatment of experimental bacterial keratitis with topical trovafloxacin.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Colony Count, Microbial; Cornea; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Ophthalmic Solutions; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Streptococcal Infections | 2004 |
Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Cornea; Eye Infections, Bacterial; Fluoroquinolones; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Serratia Infections; Serratia marcescens | 2004 |
Adverse corneal events associated with corneal reshaping: a case series.
Topics: Adult; Anti-Bacterial Agents; Child; Contact Lenses; Corneal Ulcer; Eye Infections, Bacterial; Female; Foreign-Body Reaction; Humans; Male; Myopia; Ofloxacin; Serratia Infections; Serratia marcescens | 2004 |
Postoperative Corynebacterium macginleyi endophthalmitis.
Topics: Aged; Aqueous Humor; Bacterial Typing Techniques; Cataract Extraction; Chronic Disease; Corynebacterium; Corynebacterium Infections; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Gene Amplification; Humans; Lens Implantation, Intraocular; Male; Ofloxacin; Polymerase Chain Reaction; Postoperative Complications; Tobramycin; Vancomycin; Vitreous Body | 2004 |
A retrospective study of endophtalmitis rates comparing quinolone antibiotics.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cross-Sectional Studies; Databases, Factual; Drug Utilization Review; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Male; Middle Aged; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Retrospective Studies; Utah | 2005 |
Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Ofloxacin; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Taurine; Thiadiazines | 2005 |
[Antimicrobial susceptibility surveillance of recent isolates from ophthalmological infections to gatifloxacin and other antimicrobial drugs].
Topics: Anti-Infective Agents; Drug Resistance, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Quinolones | 2005 |
Microbiological analysis of chronic dacryocystitis.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Chronic Disease; Corynebacterium diphtheriae; Dacryocystitis; Eye Infections, Bacterial; Female; Gentamicins; Humans; Lacrimal Apparatus; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Staphylococcus | 2005 |
Reduction of conjunctival bacterial flora by povidone-iodine, ofloxacin and chlorhexidine in an outpatient setting.
Topics: Anti-Infective Agents, Local; Antibiotic Prophylaxis; Bacteria; Chlorhexidine; Colony Count, Microbial; Conjunctiva; Endophthalmitis; Eye Infections, Bacterial; Humans; Ofloxacin; Ophthalmic Solutions; Outpatients; Povidone-Iodine | 2005 |
Fluoroquinolone therapy in Mycobacterium chelonae keratitis after lamellar keratectomy.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Cornea; Corneal Transplantation; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Keratitis; Levofloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ofloxacin; Rabbits | 2005 |
Characteristics of Pseudomonas corneal infection related to orthokeratology.
Topics: Administration, Topical; Adolescent; Anti-Bacterial Agents; Cefmenoxime; Cefozopran; Cephalosporins; Contact Lenses; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
A retrospective study of endophthalmitis rates comparing quinolone antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization Review; Endophthalmitis; Eye Infections, Bacterial; Humans; Incidence; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Retrospective Studies; Utah | 2005 |
A retrospective study of endophthalmitis rates comparing quinolone antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization Review; Endophthalmitis; Eye Infections, Bacterial; Humans; Incidence; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Retrospective Studies; Utah | 2005 |
A retrospective study of endophthalmitis rates comparing quinolone antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization Review; Endophthalmitis; Eye Infections, Bacterial; Humans; Incidence; Ofloxacin; Phacoemulsification; Postoperative Complications; Prevalence; Retrospective Studies; Utah | 2005 |
Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ofloxacin; Ophthalmic Solutions; Quinolines; Rabbits | 2006 |
A study of bacterial isolates from corneal specimens and their antibiotic resistance profile.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Child; Child, Preschool; Cornea; Drug Resistance, Microbial; Eye Infections, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Retrospective Studies | 2006 |
Pseudomonas keratitis.
Topics: Adolescent; Anti-Bacterial Agents; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Gentamicins; Humans; Male; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Welding | 2006 |
Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Ciprofloxacin; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Levofloxacin; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Staphylococcal Infections; Vitreous Body | 2007 |
Antibiotic effects of WP-0405, a thermo-setting ofloxacin gel, on methicillin-resistant Staphylococcus aureus keratitis in rabbits.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aqueous Humor; Biological Availability; Ciliary Body; Colony Count, Microbial; Conjunctiva; Cornea; Disease Models, Animal; Eye Infections, Bacterial; Gels; Keratitis; Male; Methicillin; Methicillin Resistance; Ofloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution | 2006 |
ESCRS study of endophthalmitis prophylaxis.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Europe; Eye Infections, Bacterial; Humans; Injections; Ofloxacin; Phacoemulsification; Postoperative Complications | 2006 |
Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections.
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines | 2006 |
Failure of Listeria monocytogenes keratitis to respond to topical ofloxacin.
Topics: Adolescent; Anti-Bacterial Agents; Cornea; Drug Resistance, Bacterial; Eye Infections, Bacterial; Humans; Keratitis; Listeria monocytogenes; Listeriosis; Male; Ofloxacin; Ophthalmic Solutions; Treatment Failure | 2006 |
In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Brazil; Ciprofloxacin; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; In Vitro Techniques; Incidence; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2007 |
Cytotoxic effects of the fluoroquinolone ofloxacin on stromal keratocytes.
Topics: Animals; Anti-Infective Agents; Corneal Stroma; Disease Models, Animal; Eye Infections, Bacterial; Humans; Keratitis; Ofloxacin; Ophthalmic Solutions; Rabbits; Risk Factors; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery.
Topics: Adult; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Health Personnel; Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Methicillin; Methicillin Resistance; Middle Aged; Ofloxacin; Photorefractive Keratectomy; Postoperative Complications; Refractive Surgical Procedures; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Surgical Flaps; Vancomycin | 2007 |
Penetration of topically applied levofloxacin into eyes with thin-wall filtering bleb after trabeculectomy.
Topics: Adult; Aged; Anti-Bacterial Agents; Aqueous Humor; Cataract Extraction; Eye Infections, Bacterial; Female; Filtering Surgery; Humans; Intraocular Pressure; Levofloxacin; Male; Middle Aged; Ofloxacin; Trabeculectomy | 2008 |
Prophylaxis of postoperative endophthalmitis.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections; Ofloxacin; Postoperative Complications | 2007 |
Infectious crystalline keratopathy caused by Gemella haemolysans.
Topics: Anti-Bacterial Agents; Cefuroxime; Colony Count, Microbial; Corneal Diseases; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Staphylococcaceae | 2007 |
Postoperative endophthalmitis caused by Bacillus cereus and Chlamydia trachomatis.
Topics: Administration, Oral; Administration, Topical; Aged; Anti-Bacterial Agents; Bacillus cereus; Bacterial Typing Techniques; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Fluorescent Antibody Technique, Direct; Gram-Positive Bacterial Infections; Humans; Lens Implantation, Intraocular; Middle Aged; Ofloxacin; Oxytetracycline; Phacoemulsification; Polymyxin B; Postoperative Complications; Vitreous Body | 2007 |
Gemella haemolysans infectious crystalline keratopathy.
Topics: Anti-Bacterial Agents; Cefuroxime; Colony Count, Microbial; Corneal Diseases; Drug Therapy, Combination; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Ofloxacin; Staphylococcaceae | 2008 |
Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chromatography, High Pressure Liquid; Ciprofloxacin; Cornea; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Norfloxacin; Ofloxacin; Ophthalmic Solutions | 1995 |
Comparative study on topical and oral administration of ofloxacin for Pseudomonas corneal ulcer in rabbits.
Topics: Administration, Oral; Administration, Topical; Animals; Cornea; Corneal Ulcer; Eye Infections, Bacterial; Female; Ofloxacin; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 1995 |
Fluoroquinolones for the eye.
Topics: Chloramphenicol; Ciprofloxacin; Eye Infections, Bacterial; Gram-Negative Bacterial Infections; Humans; Ofloxacin | 1994 |
Therapeutic intervention with chicken egg white ovomacroglobulin and a new quinolone on experimental Pseudomonas keratitis.
Topics: alpha-Macroglobulins; Animals; Cathepsin G; Cathepsins; Egg Proteins, Dietary; Eye Infections, Bacterial; Keratitis; Leukocyte Elastase; Macroglobulins; Male; Ofloxacin; Pancreatic Elastase; Pseudomonas; Pseudomonas Infections; Rabbits; Serine Endopeptidases | 1994 |
Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Clinical Trials as Topic; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Ofloxacin; Randomized Controlled Trials as Topic; Tobramycin | 1996 |
Delayed-onset Pseudomonas keratitis after radial keratotomy.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Astigmatism; Cornea; Corneal Ulcer; Doxycycline; Eye Infections, Bacterial; Humans; Keratotomy, Radial; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections | 1997 |
Bilateral corneal infection as a complication of laser in situ keratomileusis.
Topics: Adolescent; Cilastatin; Cornea; Corneal Diseases; Corneal Transplantation; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Imipenem; Injections, Intravenous; Laser Therapy; Male; Ofloxacin; Ointments; Ophthalmic Solutions; Protease Inhibitors; Staphylococcal Infections; Staphylococcus aureus | 1997 |
Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Drug Delivery Systems; Eye Infections, Bacterial; Keratitis; Ofloxacin; Ophthalmic Solutions; Polystyrenes; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 1998 |
Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.
Topics: Anti-Infective Agents; Ciprofloxacin; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Ofloxacin; Pennsylvania; Retrospective Studies | 1999 |
The effect of long-term use and inflammation on the ocular penetration of topical ofloxacin.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Aqueous Humor; Endophthalmitis; Eye; Eye Infections, Bacterial; Female; Male; Ofloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vitreous Body | 1999 |
Effect of topical povidone-iodine versus topical ofloxacin on experimental Staphylococcus keratitis.
Topics: Animals; Anti-Infective Agents; Colony Count, Microbial; Cornea; Disease Models, Animal; Eye Infections, Bacterial; Iodophors; Keratitis; Male; Ofloxacin; Ophthalmic Solutions; Povidone-Iodine; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2000 |
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Bacterial; Florida; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Ofloxacin; Retrospective Studies; Tobramycin | 2000 |
In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Eye Infections, Bacterial; Humans; In Vitro Techniques; Ofloxacin | 2000 |
The effectiveness of a topical antibiotic irrigating solution in a model of staphylococcal keratitis after lamellar keratectomy.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Colony Count, Microbial; Corneal Stroma; Corneal Transplantation; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Microbial Sensitivity Tests; Ofloxacin; Ophthalmic Solutions; Rabbits; Safety; Staphylococcal Infections; Staphylococcus aureus; Therapeutic Irrigation; Treatment Outcome | 2000 |
Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis.
Topics: Anti-Infective Agents; Bacteria; Cornea; Corneal Diseases; Corneal Ulcer; Eye Infections, Bacterial; Humans; Incidence; Ofloxacin; Retrospective Studies; Rupture, Spontaneous | 2001 |
In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Eye Infections, Bacterial; Microbial Sensitivity Tests; Ofloxacin | 2001 |
Bacillus circulans endophthalmitis.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bacillaceae Infections; Bacillus; Cephalosporins; Cephalothin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Lens Capsule, Crystalline; Microbial Sensitivity Tests; Ofloxacin; Prednisolone; Vitrectomy | 2001 |
An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Microbial; Eye Infections, Bacterial; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus aureus; Time Factors | 2001 |
Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis.
Topics: Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Ciprofloxacin; Colony Count, Microbial; Cornea; Eye Infections, Bacterial; Keratitis; Ofloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2001 |
The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Colony Count, Microbial; Corneal Stroma; Eye Infections, Bacterial; Keratitis; Microbial Sensitivity Tests; Ofloxacin; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2001 |
Infectious keratitis in orthokeratology.
Topics: Acanthamoeba Keratitis; Adult; Antiprotozoal Agents; Astigmatism; Benzamidines; Chloramphenicol; Contact Lenses; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Ketoconazole; Male; Middle Aged; Myopia; Ofloxacin; Pseudomonas Infections | 2002 |
Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies | 2002 |
Anti-inflammatory therapy and outcome in a guinea pig model of Pseudomonas keratitis.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dicarboxylic Acids; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Flurbiprofen; Guinea Pigs; Keratitis; Masoprocol; Ofloxacin; Prednisolone; Pseudomonas Infections; Random Allocation; SRS-A | 1992 |
Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model.
Topics: Administration, Topical; Animals; Aqueous Humor; Chromatography, High Pressure Liquid; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Ofloxacin; Pseudomonas Infections; Rabbits; Tobramycin | 1992 |
[Pseudomonas aeruginosa ocular infection].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Microbial; Eye Infections, Bacterial; Female; Humans; Ofloxacin; Orbital Diseases; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors | 1991 |